Product Information

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.9895 per EA under NDC 33342024710. Its NADAC has been published 42 times since Dec 17, 2025.

FDA first approved this application on Jul 18, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG

Olmesartan medoxomil Amlodipine and Hydrochlorothiazide
$0.9895per EA

Strength

10; 25; 40 mg/1; mg/1; mg/1

NDC

33342024710

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207088

FDA Approved

7/18/2025

TE Code

AB

On Market Since

7/18/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9895 per EA
All-time high$1.3690 (Jan 14, 2026)
All-time low$0.9895 (Sep 23, 2026)
52-week high$1.3690
52-week low$0.9895
Median price$1.1651
Average price$1.1867
Largest weekly change-9.4% (Aug 19, 2026)
Weeks tracked42
Tracking sinceDec 17, 2025

Price History

1W

0.0%

1M

-4.3%

3M

-15.1%

6M

-16.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

-27.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.9895 per EA (NDC 33342024710), effective Sep 30, 2026.

How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG changed over time?

Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG has declined 27.7%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

Since Dec 17, 2025, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG has ranged from a low of $0.9895 (Sep 23, 2026) to a high of $1.3690 (Jan 14, 2026), with a median of $1.1651 per EA.

Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG?

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG (NDC 33342024710) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.